Evaluation of tumor-infiltrating lymphocites (TIL) and response to neoadjuvant chemotherapy according to RCB index in a series of 157 breast cancer cases. (April 2018) - Petit Montserrat, A.; Azcarate, J.; Espejo-Herrera, N.; Soler-Monso, M.T.; Varela, M.; Perez, X.; Falo, C.; Morilla, I.; Gil-Gil, M.; Maria Jesus, P.; Pau, T.; Taco, M.D.R.; et al.